1
A PowderJect device was used to immunize mice with the powder vaccine via their abdominal skin.
2
These toxoid fusions were used to immunize mice and were characterized for induction of anti-STa antibody response.
3
When used to immunize mice, the protein induced a strong protective response against a challenge with the parasite.
4
They used a process called electroporation, which employs an electrical pulse, to force the compound through skin and muscle to immunize mice.
5
Cultured spleen cells from immunized mice were tested for their cytokine content.
6
We also immunized mice with these antigens and assessed the IgG response.
7
Sera from all groups of immunized mice reacted with the extracts tested.
8
Both serum and intestinal CTB-specific antibodies were induced in orally immunized mice.
9
We found that twice- immunized mice were protected against challenge with the wild-type virus.
10
Immunized mice were resistant to challenge with a lethal viral dose.
11
Immunized mice became more resistant to virulent EV71 strain challenge than nonimmunized mice.
12
Moreover, potent adaptive and innate immune responses were stimulated in the OMV- immunized mice.
13
BKCa channel β1-subunit expression was reduced in the mesenteric arteries of immunized mice.
14
Anti-EC antibodies cause EC apoptosis in vitro and emphysema in passively immunized mice.
15
OspA-GT- immunized mice resisted syringe challenge but developed disseminated infections following transplantation of infected skin.
16
The humoral immune response in immunized mice is qualitatively similar to that in humans.